Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:42 PM
Ignite Modification Date:
2025-12-24 @ 12:42 PM
NCT ID:
NCT07286461
Eligibility Criteria:
Inclusion Criteria:
* Be \> 18 years of age
* Sign an informed consent
* HSCT recipients seropositive to CMV, or receiving HSCs from a CMV seropositive donor
* Antiviral prophylaxis with letermovir for preventing CMV infection will be administered for 100 days in Italy (or 200 days in Germany) after HSCT to all participants according to the current guidelines
Exclusion Criteria:
Individuals \<18 years old undergoing HSCT Individuals not receiving letermovir prophylaxis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07286461
Study Brief:
Protocol Section:
NCT07286461